Transcatheter aortic valve implantation in patients with low-flow, low-gradient aortic stenosis
JACC Cardiovascular Interventions, 06/08/2012
Lauten A et al. – In high–risk patients with LG–AS, TAVI is associated with a significantly higher mortality at 30 days and at 1 year. However, long–term survivors benefit from TAVI with functional improvement and a significantly increased quality of life. Therefore, in view of the poor prognosis with medical treatment, TAVI should be considered an option in high–risk patients with LG–AS.